✦ LIBER ✦

Sa1108 Cost-Effectiveness of Golimumab Versus Infliximab and Adalimumab for the Treatment of Moderate to Severe Ulcerative Colitis

✍ Scribed by Thorlund, Kristian; Druyts, Eric; Kanters, Steve; Eapen, Shawn; Mills, Edward

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-Effectiveness Of Infliximab Versus

✍ Goszczyńska, K.; Wrona, W.; Niewada, M.; Black, C.M.; Fan, T.; Lobodzinski, P. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

Mo1325 Cost-Effectiveness of Infliximab

✍ Monfared, Amir A. Tahami; Feagan, Brian G. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 227 KB

Cost-per-remission analysis of inflixima

✍ Lofland, Jennifer H.; Mallow, Peter; Rizzo, John 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 109 KB

A model of the long-term cost effectiven

✍ H. H. TSAI; Y. S. PUNEKAR; J. MORRIS; P. FORTUN 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 471 KB

Sa2032 Infliximab for Moderate to Severe

✍ Ron, Yulia; Yanai, Henit; Yehoyada, Merav Ben; Meirovithz, Elhanan; Yahav, Lior; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 82 KB

Adalimumab versus infliximab for the tre

✍ Thorlund, Kristian; Druyts, Eric; Mills, Edward J.; Fedorak, Richard N.; Marshal 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 482 KB